XML 49 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814
Revenue Recognition (Policies)
9 Months Ended
Sep. 30, 2015
Revenue Recognition [Abstract]  
Revenue Recognition
6.
Revenue Recognition

Concentration of Significant Customers
One distributor and three direct customers comprised 72% of our revenue recognized for the three months ended September 30, 2015. Two distributors and three direct customers comprised 67% of our revenue recognized for the nine months ended September 30, 2015.  Three distributors and three direct customers accounted for 63% of total outstanding accounts receivable as of September 30, 2015.
 
Five distributors comprised 62% of our revenue recognized for the nine months ended September 30, 2014. Three distributors accounted for 92% of total outstanding accounts receivable as of December 31, 2014.
 
Product revenues, classified by geographic location, are as follows:

  
Three months ended
    
Nine months ended
 
                 
  
September 30, 2015
  
September 30, 2014
  
September 30, 2015
  
September 30, 2014
 
  
Product Revenues
  
% of Total
  
Product Revenues
  
% of Total
  
Product Revenues
  
% of Total
  
Product Revenues
  
% of Total
 
                 
Americas  
 
$
120,000
   
16
%
 
$
175,000
   
34
%
 
$
597,000
   
18
%
 
$
614,000
   
25
%
Japan  
  
451,000
   
59
%
  
60,000
   
12
%
  
1,408,000
   
43
%
  
1,323,000
   
53
%
Europe  
  
75,000
   
10
%
  
271,000
   
52
%
  
491,000
   
15
%
  
535,000
   
22
%
Asia Pacific  
  
120,000
   
16
%
  
12,000
   
2
%
  
785,000
   
24
%
  
12,000
   
0
%
Total product revenues  
 
$
766,000
   
100
%
 
$
518,000
   
100
%
 
$
3,281,000
   
100
%
 
$
2,484,000
   
100
%

Research and Development

We earn revenue for performing tasks under research and development agreements with governmental agencies like the BARDA. Revenues derived from reimbursement of direct out-of-pocket expenses for research costs associated with government contracts are recorded as government contract and other within development revenues.  Government contract revenue is recorded at the gross amount of the reimbursement.  The costs associated with these reimbursements are reflected as a component of research and development expense in our statements of operations.   We recognized $1.7 million and $5 million in BARDA revenue for the three and nine months ended September 30, 2015, respectively as compared to $0.6 million and $1.3 million for the three and nine months ended September 30, 2014, respectively.